1. Recognize that migraine occurs with brain hyperexcitability;
2. Recognize the potential utility of nose-to-brain neurotherapeutics; and
3. Recognize the interrelation of IGF-1 and CGRP in preclinical studies of migraine


Session date: 
Thursday, June 21, 2018 - 3:00pm to 4:00pm
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Richard P. Kraig MD PhD